Xerostomia clinical trials

Explore recruiting xerostomia clinical trials.

Recruiting xerostomia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Xerostomia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prevention of radiation-induced salivary gland damage by botulinum toxin application in patients with head and neck cancers

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

DUET-study: A FEASIBILITY STUDY OF 177LU-PSMA RADIOLIGAND THERAPY ALTERNATED WITH RADIUM-223 IN PATIENTS WITH BONE-METASTATIC, OLIGO-METASTATIC HORMONE-SENSITIVE PROSTATE CANCER AFTER CURATIVE THERAPY.

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

SAFETY AND POTENTIAL EFFECT OF INNOVATIVE CELL-BASED THERAPY USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION IN PATIENTS WITH AUTOIMMUNE XEROSTOMIA (STUDY XEROCELL)

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Intraglandular treatment with adipose derived mesenchymal stem cells in patients with xerostomia due to Sjögrens syndrome (ASSIX)

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Xerostomia in patients with a life-limiting condition or frailty: a double-blind placebo-controlled randomized clinical trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Xerostomia trials by city

Xerostomia in Toronto Xerostomia in Vancouver Xerostomia in Montreal Xerostomia in Calgary Xerostomia in Edmonton Xerostomia in Ottawa Xerostomia in Winnipeg Xerostomia in Quebec City Xerostomia in Hamilton Xerostomia in Kitchener Xerostomia in London Xerostomia in Halifax Xerostomia in New York Xerostomia in Los Angeles Xerostomia in Chicago Xerostomia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease